EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Performance Characterization of BODIPY‐Based NIR Probes for Aβ 42 Aggregate Detection

Jiaoru Chen, Xueling Ding, Dezhong Guan, Shilong Zhu, Xiaoyi Zhang, Lingfeng Xie, Jinpei Zhou iD, Huibin Zhang iD

ChemPlusChem · 2026

DOI: 10.1002/cplu.70196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemPlusChem, 2026. Verfasst von Jiaoru Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Drug Discovery, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, P. R. China. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Boron Compounds, Fluorescent Dyes, Peptide Fragments. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a progressive neurodegenerative disease with typical pathological features including β‐amyloid (Aβ) plaques. Achieving early and accurate detection of cerebral Aβ aggregates is essential for timely intervention in AD, but the process is challenging. To address the lack of high‐sensitivity and high signal‐to‐noise ratio near‐infrared imaging tools for the early pathological detection of Aβ, we designed and synthesized two BODIPY‐quinoline‐based fluorescent probes, BQ‐1 and BQ‐2 , for targeting Aβ 42 aggregates. BQ‐1 showed high affinity ( K D = 48.81 nM), high sensitivity (LOD = 52 nM), and high signal‐to‐noise ratio (189.5‐fold) for Aβ 42 aggregates. Based on the twisted intramolecular charge transfer (TICT) mechanism, BQ‐1 showed near‐infrared fluorescence emission ( λ ex / λ em = 612/669 nm, Stokes shift 57 nm) after binding to Aβ 42 aggregates, which showed good optical properties. Cell imaging experiments showed that BQ‐1 could label Aβ 42 aggregates in PC12 cells with high selectivity and low cytotoxicity. This study demonstrates that BQ‐1 is a near‐infrared (NIR) fluorescent probe with excellent performance and provides a potential tool for early pathological imaging diagnosis of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesBoron CompoundsFluorescent DyesPeptide FragmentsDrug DesignAnimalsPC12 CellsRatsFluorescent Chemosensor CompoundsAlzheimer DiseaseHumansProtein Aggregates

Stichwörter der Autor:innen

Alzheimer’s diseaseAβ aggregatesBODIPYcell imagingnear‐infrared fluorescent probe

Substanzen

Amyloid beta-PeptidesBoron Compounds4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneFluorescent Dyesamyloid beta-protein (1-42)Peptide FragmentsFluorescent Chemosensor CompoundsProtein Aggregates

Autor:innen und Institutionen

  • Center of Drug Discovery, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, P. R. China.
  • Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing, P. R. China.

ORCID-Profile: Jinpei Zhou, Huibin Zhang

Zitieren

APA

Chen, J., Ding, X., Guan, D., Zhu, S., Zhang, X., Xie, L., Zhou, J., & Zhang, H. (2026). Design, Synthesis, and Performance Characterization of BODIPY‐Based NIR Probes for Aβ 42 Aggregate Detection. ChemPlusChem. https://doi.org/10.1002/cplu.70196

Vancouver

Chen J, Ding X, Guan D, Zhu S, Zhang X, Xie L, et al. Design, Synthesis, and Performance Characterization of BODIPY‐Based NIR Probes for Aβ 42 Aggregate Detection. ChemPlusChem. 2026. doi:10.1002/cplu.70196

BibTeX
@article{Chen2026,
  author = {Chen, Jiaoru and Ding, Xueling and Guan, Dezhong and Zhu, Shilong and Zhang, Xiaoyi and Xie, Lingfeng and Zhou, Jinpei and Zhang, Huibin},
  title = {Design, Synthesis, and Performance Characterization of BODIPY‐Based NIR Probes for Aβ 42 Aggregate Detection},
  journal = {ChemPlusChem},
  year = {2026},
  doi = {10.1002/cplu.70196}
}
Kostenlos starten →